Stuart Tross - Amgen Insider

Amgen Inc -- USA Stock  

USD 170.12  0.16  0.0941%

Senior Vice President - Human Resources

Dr. Stuart A. Tross is the Senior Vice President Human Resources of Amgen Inc
Age: 48  President Since 2013      
805 447-1010  www.amgen.com
Tross joined the Company in April 2006 as Vice President, Human Resources. Prior to joining Amgen, from November 1998 to April 2006, Dr. Tross served in a series of roles for BMS, with his last position being Vice President and Global Head of Human Resources of Mead Johnson Nutrition. Prior to joining BMS, Dr. Tross was a management consultant for Towers Perrin.

Management Efficiency

The company has return on total asset (ROA) of 8.27 % which means that it generated profit of $8.27 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 26.43 % meaning that it created $26.43 on every $100 dollars invested by stockholders.
The company currently holds 35.06 B in liabilities with Debt to Equity (D/E) ratio of 110.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 6.08 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

William MeuryAllergan plc
2016
J WhiteAbbott Laboratories
2013
Jeffrey ChodakewitzVertex Pharmaceuticals Incorpor
2014
Murthy SimhambhatlaAbbott Laboratories
2013
Heather MasonAbbott Laboratories
2015
Michael WarmuthAbbott Laboratories
2012
Daniel SalvadoriAbbott Laboratories
2014
Amit SachdevVertex Pharmaceuticals Incorpor
2017
Blaise ColemanEndo International plc
2016
Brian LortieEndo International plc
N/A
Deepak NathAbbott Laboratories
2015
Thomas GraneyVertex Pharmaceuticals Incorpor
2017
Philippe SchaisonAllergan plc
2015
John HertiaBio Rad Laboratories Inc
2014
Ronald HuttonBio Rad Laboratories Inc
2012
Paul NavarreAllergan plc
Andrew LaneAbbott Laboratories
2015
Robert FordAbbott Laboratories
2015
Joseph ManningAbbott Laboratories
2017
Robert FunckAbbott Laboratories
2013
Charles FoltzAbbott Laboratories
2013

Entity Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 17,900 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Equity Search Now
   

Equity Search

Search for activelly-traded equities including funds and ETFs from over 30 global markets
Hide  View All  NextLaunch Equity Search
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Amgen Inc to your portfolio

Top Management

Amgen Inc Leadership Team
Frank Herringer, Director
R Williams, Director
Francois Carbonnel, Director
Rebecca Henderson, Director, Ph.D
Annette Such, Executive
Sanders Williams, Director
Vance Coffman, Director, Ph.D
Tyler Jacks, Director, Ph.D
Brian McNamee, President
Gregory Garland, Director
Charles Holley, Director
Esteban Santos, President
Jonathan Graham, President
Sean Harper, President, Ph.D
Ellen Kullman, Director
Frank Biondi, Director
Arvind Sood, Executive
David Meline, CFO
Ronald Sugar, Director
Stuart Tross, President
Robert Bradway, Chairman
Robert Eckert, Director
Madhavan Balachandran, EVP
Lori Johnston, President
Cynthia Patton, President
Greg Garland, Director
Judith Pelham, Director
David Baltimore, Director, Ph.D
Fred Hassan, Director
David Piacquad, President
Anthony Hooper, EVP

Stock Performance

Amgen Performance Indicators